September 18 marked the first day of Prostate Cancer Awareness Week, 2000. This year, it is estimated that over 180,000 new cases of prostate cancer will be detected in the US and 32,000 men will die from the disease - that is one diagnosis every three minutes, and one death every 13 minutes. Over a lifetime, prostate cancer will effect an estimated one in six American men. African American men have the highest prostate cancer rates in the world. They are least 50% more likely to develop prostate cancer than men of other racial and ethnic groups and are also more than twice as likely to die from it.
AstraZeneca, a pharmaceutical and healthcare company, is partnering with companies across the nation to educate the importance of screening and early detection. The screening programs, entitled "Corporate Fight Against Prostate Cancer", include employee education, the provision and display of materials, and lunchtime seminars conducted by local urologists. Onsite screenings are also being made available. For more information visit the Prostate Cancer Education Council at www.pcaw.com.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.